Effect of Irisin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
Journal of Biochemical and Molecular Toxicology · 2026-04 · 40 (4)
DOI: 10.1002/jbt.70692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 29.03.2026. Verfasst von Mengting Tian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Prosthetics and implantology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Cell Differentiation, Fibronectins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
To investigate the effect of irisin on the osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs) and bone regeneration in a femoral defect model. Rat BMSCs were treated with irisin in vitro, and osteogenic markers were analysed using reverse transcription quantitative polymerase chain reaction. In vivo, irisin‐loaded composite scaffolds or blank scaffolds were implanted into rat femoral defects ( n = 6 per group). Bone repair was assessed by micro‐computed tomography, haematoxylin and eosin staining, and immunohistochemistry after 8 weeks. Irisin treatment significantly enhanced calcium nodule formation, as evidenced by increased staining intensity, size and number in both Alizarin Red and von Kossa assays. At the molecular level, Sost expression was markedly downregulated, whereas ALP , Lrp5 , BMP2 and Smad1 were significantly upregulated at both mRNA levels (all p < 0.001). In vivo, rats implanted with irisin‐composite scaffolds showed substantially improved bone repair, with higher bone volume fraction, bone mineral density and cortical bone volume compared with controls. Irisin promotes the osteogenic differentiation of rat BMSCs and accelerates bone regeneration in a critical‐sized femoral defect model, potentially through suppression of Sost and subsequent activation of the Wnt and BMP signalling pathways. These findings highlight the therapeutic potential of irisin for bone tissue engineering applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dental Prosthetics and implantology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
- Department of Stomatology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
ORCID-Profile: Huiyu He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tian, M., & He, H. (2026). Effect of Irisin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells. Journal of Biochemical and Molecular Toxicology, 40(4). https://doi.org/10.1002/jbt.70692
Vancouver
Tian M, He H. Effect of Irisin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells. Journal of Biochemical and Molecular Toxicology. 2026;40(4). doi:10.1002/jbt.70692
BibTeX
@article{Tian2026,
author = {Tian, Mengting and He, Huiyu},
title = {Effect of Irisin on the Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {4},
doi = {10.1002/jbt.70692}
}
EUVIMED